# Genvion Corporation – FDA Inspection, Jul 28, 2023

Source: https://www.keypedia.com/records/fda_inspections/genvion-corporation/23b52120-0b49-4f0b-93eb-308a5358d95d
Source feed: FDA_Inspections

> FDA inspection 1216476 of Genvion Corporation, July 28, 2023. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216476
- Company Name: Genvion Corporation
- Inspection Date: 2023-07-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 985034 - 2016-06-17](https://www.keypedia.com/records/fda_inspections/genvion-corporation/a09be837-b79c-4a95-8b3c-24945748ebb0)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joey-v-quitania/faae874f-94ea-4b63-89d1-649e60726f6f)

Company: https://www.keypedia.com/companies/genvion-corporation/a4655b0c-e1a8-4645-bd02-3bcb514a08ce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c